Salvage Radical Prostatectomy in Nonmetastatic Castration-Resistant Prostate Cancer

被引:2
作者
Lopez-Fontana, Gaston [1 ]
Manuel Guglielmi, Juan [1 ]
Lopez-Fontana, Rodrigo [1 ]
Lis Hinojosa-Jury, Mariana [2 ]
Lopez-Fontana, Constanza [3 ]
Daniel Lopez-Laur, Jose [1 ]
机构
[1] Andina Clin, Dept Urol, Mendoza, Argentina
[2] Italian Hosp, Mendoza, Argentina
[3] Inst Med & Expt Biol, Mendoza, Argentina
来源
ARCHIVOS ESPANOLES DE UROLOGIA | 2022年 / 75卷 / 07期
关键词
prostate cancer; salvage radical prostatectomy; radiotherapy; castration -resistant prostate cancer; NATURAL-HISTORY; ANTIGEN; MEN;
D O I
10.56434/j.arch.esp.urol.20227507.92
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the perioperatory and short-oncological outcomes in 5 cases with CRPC M0 developed after pRT that underwent salvage laparoscopic RP (sLRP) and review the current evidence. Material and Methods: Perioperatory and oncological outcomes were prospectively analyzed. Inclusion criteria were patients that had received pRT and posteriorly presented with CRPC M0 in standard imagines and positron emission tomography MRI coline. Evidence was reviewed in PUBMED database. Results: No surgical complications and blood transfusion were reported. Two patients required an endoscopic urethrotomy due to bladder neck contracture (Clavien IIIb). Final pathological findings were T3 or more, multifocal with 3 positive surgical margins. Four patients reach undetectable PSA after surgery except one that continuous under ADT without disease progression. After 12 months follow-up, 4 patients persist with undetectable PSA and one with stable disease under ADT. Current evidence demonstrated that CRPC M0 treated with open, laparoscopic or robotic RP a biochemical recurrence of 68.7% as a hormonesensitive PC however, 17.4% were disease-free after 4 years of follow-up. Conclusion: Our serie, 4 cases are disease free after 12 months follow-up. Current evidence is a retrospective and multicenter experience with few cases and intermediate oncological follow-up. More cases with longer follow-up and better evidence are required to opt for this treatment as a first line.
引用
收藏
页码:638 / 641
页数:4
相关论文
共 16 条
[1]   Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer [J].
Afshar-Oromieh, Ali ;
Zechmann, Christian M. ;
Malcher, Anna ;
Eder, Matthias ;
Eisenhut, Michael ;
Linhart, Heinz G. ;
Holland-Letz, Tim ;
Hadaschik, Boris A. ;
Giesel, Frederik L. ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) :11-20
[2]  
[Anonymous], US
[3]   Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence [J].
Boorjian, Stephen A. ;
Thompson, R. Houston ;
Tollefson, Matthew K. ;
Rangel, Laureano J. ;
Bergstralh, Eric J. ;
Blute, Michael L. ;
Karnes, R. Jeffrey .
EUROPEAN UROLOGY, 2011, 59 (06) :893-899
[4]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[5]   National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening [J].
Drazer, Michael W. ;
Huo, Dezheng ;
Eggener, Scott E. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (22) :2416-U18
[6]   Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches [J].
Gontero, Paolo ;
Marra, Giancarlo ;
Alessio, Paolo ;
Filippini, Claudia ;
Oderda, Marco ;
Munoz, Fernando ;
Linares, Estefania ;
Sanchez-Salas, Rafael ;
Challacombe, Ben ;
Dasgupta, Prokar ;
Goonewardene, Sanchia ;
Popert, Rick ;
Cahill, Declan ;
Gillatt, David ;
Persad, Raj ;
Palou, Juan ;
Joniau, Steven ;
Piechaud, Thierry ;
Morlacco, Alessandro ;
Vidit, Sharma ;
Roupret, Morgan ;
De La Taille, Alexandre ;
Albisinni, Simone ;
Gandaglia, Giorgio ;
Mottrie, Alexander ;
Joshi, Shreyas ;
Fiscus, Gabriel ;
Berger, Andre ;
Aron, Monish ;
Van der Poel, Henk ;
Tilki, Derya ;
Lawrentschuk, Nathan ;
Murphy, Declan G. ;
Leung, Gordon ;
Davis, John ;
Karnes, Robert Jeffrey ;
Calleris, Giorgio ;
Munegato, Stefania ;
Palazzetti, Anna ;
Pisano, Francesca ;
Ricardi, Umberto ;
Pisano, Francesca ;
Battaglia, Antonino ;
van Velthoven, Roland ;
Cathcart, Paul ;
Smelzo, Salvatore ;
Smith, Joseph ;
Abreu, Andre ;
Gill, Inderbir S. .
JOURNAL OF UROLOGY, 2019, 202 (04) :725-731
[7]   Salvage Radical Prostatectomy in Nonmetastatic Castration-resistant Prostate Cancer Patients Who Received Previous Radiotherapy: A Feasibility Study [J].
Gontero, Paolo ;
Spahn, Martin ;
Marchioro, Giansilvio ;
Karnes, Jeffrey R. ;
Briganti, Alberto ;
Frea, Bruno ;
Ricardi, Umberto ;
van Poppel, Hendrik ;
Joniau, Steven .
EUROPEAN UROLOGY, 2014, 65 (01) :254-255
[8]  
Guillonneau B, 2000, J UROLOGY, V163, P1643, DOI 10.1016/S0022-5347(05)67512-X
[9]   EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [J].
Heidenreich, Axel ;
Bastian, Patrick J. ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
van der Kwast, Theodor ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Wiegel, Thomas ;
Zattoni, Filiberto ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2014, 65 (02) :467-479
[10]   Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer [J].
Hussain, Maha ;
Fizazi, Karim ;
Saad, Fred ;
Rathenborg, Per ;
Shore, Neal ;
Ferreira, Ubirajara ;
Ivashchenko, Petro ;
Demirhan, Eren ;
Modelska, Katharina ;
Phung, De ;
Krivoshik, Andrew ;
Sternberg, Cora N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26) :2465-2474